Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.
D015065:17-Hydroxycorticosteroids / Q000097:blood*; D000368:Aged; D001667:Binding, Competitive; D002986:Clinical Trials as Topic; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005470:Fluorometry; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D010919:Placebos; D011379:Prognosis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000401:mortality* / Q000601:surgery; D011485:Protein Binding
D015065:17-Hydroxycorticosteroids; D004966:Estrogens, Conjugated (USP); D010919:Placebos; D004054:Diethylstilbestrol; D008525:Medroxyprogesterone; D006854:Hydrocortisone